4D Molecular Therapeutics • FDMT
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors.
Ratings
1 / 5
1 rating in the last 12 months
5
4
3
2
1
CEO
Mr. David Kirn, M.D.$956.5M
Market Cap • 25/07/20242015
(há 9 anos)
2020
(4 years ago)
NASDAQ
Listagem
Emeryville
Sede • California140
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
FDMTSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.